HNDRX Mutual Fund

HNDRX Mutual Fund

NAV$91.39
See how much of HNDRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$1.1B
Expense Ratio
1.04%
Dividend Yield (Current)
0.19%
Holdings
516
Inception Date
Dec 28, 2017
Fund Family
Horizon Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+6.92%
1 Year+7.93%
3 Year+13.42%
5 Year+7.99%

Asset Allocation

Stocks: 92.41%
Other: 7.59%
See how much of HNDRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
NVDANVIDIA Corp7.20%
AAPLApple Inc6.13%
MAGSRoundhill Magnificent Seven Etf5.86%
MSFTMicrosoft Corp4.33%
AMZNAmazon.com Inc2.96%
Top 10 Concentration: 36.72%Report Date: Aug 31, 2026
Download all 516 holdings for HNDRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.19%
Frequency
Annually
Latest Distribution
$0.18
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

HNDRX Mutual Fund Overview

HNDRX Mutual Fund (Horizon Defined Risk Fund Investor Class) is managed by Horizon Funds with $1.10B in net assets. HNDRX expense ratio is 1.04%, holding 516 positions across sectors including Information Technology, Financials, Health Care. Inception date: 2017-12-28.

HNDRX performance shows a YTD return of 6.92%. The 1-year return is 7.93% and the 5-year return is 7.99%. HNDRX dividend yield stands at 0.19%, paid annually.

HNDRX top holdings include NVIDIA Corp (7.2%), Apple Inc (6.1%), Roundhill Magnificent Seven Etf (5.9%), Microsoft Corp (4.3%), Amazon.com Inc (3.0%). Go to all HNDRX holdings, HNDRX sectors, or HNDRX dividends.

HNDRX can be compared against other funds. Use HNDRX overlap to find shared positions, or HNDRX vs another fund for a side-by-side view. HNDRX alternatives are available via the screener, along with tax-loss harvesting opportunities.